Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
10
Ṁ170Ṁ117Aug 12
75%
chance
1H
6H
1D
1W
1M
ALL
As implied in these tweets, among other places. Closes in 3 years.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
57% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
51% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
16% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
88% chance
Will a study suggest GLP-1 agonists (and similar) have an effect on bulimia nervosa frequency or work as a treatment?
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
10% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms
74% chance